Hilde Hermansen Steineger

Hilde Hermansen Steineger (42) is Vice President Investor Relations and Communications at Pronova Biocare. Prior to this, she was a Senior Associate with Neomed Management.

Dr. Steineger was employed with Nycomed Pharma in the area of clinical research and international marketing from 1999 to 2001.

From 2001 to 2004, she held the position of Equity Analyst in Kreditkassen (now part of Nordea). From 2004 to 2006, she worked as an independent advisor, focusing on start-ups within the Life Science/Healthcare sector.

She is a Board member of Algeta ASA and Alertis Medical ASA and holds an M.Sc. and a PhD. in Medical Biochemistry from the University of Oslo.

Dr. Steineger is a Norwegian citizen and resides in Oslo, Norway. She holds 2,600 shares in Clavis Pharma.